Home | News | Contact | SHARE MEDIA ALERT - Momenta Applauds FDA Denial of Citizen Petition Requesting FDA Mandate of Information Sharing in Biosimilars Review Process Momenta announces launch of Glatopa™ (glatiramer acetate injection), the first substitutable generic for COPAXONE® 20mg Momenta® and the Momenta logo are registered trademarks of Momenta Pharmaceuticals, Inc. © 2015 Momenta Pharmaceuticals - All Rights Reserved | Terms of Use | Privacy | Site Map